UPDATE 3-Novartis buys dry eye drug from Takeda for up to $5.3 bln

* Deal for Shire-developed drug includes 400 Takeda staff (Adds details, comment from analyst)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.